The AAA + ATPase valosin-containing protein (VCP)/p97/Cdc48 interaction network in Leishmania

Aguiar, Bruno Guedes; Dumas, Carole; Maaroufi, Halim; Padmanabhan, Prasad K.; Papadopoulou, Barbara

doi:10.1038/s41598-020-70010-4

Download PDF

Article
Open access
Published: 04 August 2020

The AAA + ATPase valosin-containing protein (VCP)/p97/Cdc48 interaction network in Leishmania

Bruno Guedes Aguiar^1,2^nAff3,
Carole Dumas^1,2,
Halim Maaroufi⁴,
Prasad K. Padmanabhan^1,2 &
…
Barbara Papadopoulou^1,2

Scientific Reports volume 10, Article number: 13135 (2020) Cite this article

3144 Accesses
3 Citations
1 Altmetric
Metrics details

Subjects

Abstract

Valosin‐containing protein (VCP)/p97/Cdc48 is an AAA + ATPase associated with many ubiquitin-dependent cellular pathways that are central to protein quality control. VCP binds various cofactors, which determine pathway selectivity and substrate processing. Here, we used co-immunoprecipitation and mass spectrometry studies coupled to in silico analyses to identify the Leishmania infantum VCP (LiVCP) interactome and to predict molecular interactions between LiVCP and its major cofactors. Our data support a largely conserved VCP protein network in Leishmania including known but also novel interaction partners. Network proteomics analysis confirmed LiVCP-cofactor interactions and provided novel insights into cofactor-specific partners and the diversity of LiVCP complexes, including the well-characterized VCP-UFD1-NPL4 complex. Gene Ontology analysis coupled with digitonin fractionation and immunofluorescence studies support cofactor subcellular compartmentalization with either cytoplasmic or organellar or vacuolar localization. Furthermore, in silico models based on 3D homology modeling and protein–protein docking indicated that the conserved binding modules of LiVCP cofactors, except for NPL4, interact with specific binding sites in the hexameric LiVCP protein, similarly to their eukaryotic orthologs. Altogether, these results allowed us to build the first VCP protein interaction network in parasitic protozoa through the identification of known and novel interacting partners potentially associated with distinct VCP complexes.

Dynamic remodelling of the human host cell proteome and phosphoproteome upon enterovirus infection

Article Open access 28 August 2020

Insights on autophagosome–lysosome tethering from structural and biochemical characterization of human autophagy factor EPG5

Article Open access 05 March 2021

ULK1 and ULK2 are less redundant than previously thought: computational analysis uncovers distinct regulation and functions of these autophagy induction proteins

Article Open access 02 July 2020

Introduction

Leishmania species cause a large spectrum of diseases in humans ranging from skin lesions to visceral damage, which is lethal, if left untreated. Treatment options for leishmaniasis are limited and toxic and no effective vaccine is currently available (https://www.dndi.org/ diseases-projects/leishmaniasis/). Within its mammalian host, Leishmania replicates in the phagolysosome compartment of macrophages where it encounters various stress stimuli that trigger important changes in gene expression^1,2,3,4,5 and parasite metabolism^6,7. Most of those stresses lead to DNA damage or protein misfolding that has to be corrected. As many other eukaryotes⁸, Leishmania has evolved quality control systems that cooperate to eliminate damaged proteins^9,10,11,12.

Recently, we have undertaken studies to characterize the Leishmania valosin-containing protein (VCP)/p97/Cdc48 ortholog (VCP and p97 in metazoa, Cdc48 in yeast)¹⁰, one of the key quality control components in recycling or degrading misfolded proteins or aggregates. VCP belongs to the AAA + (Associated with diverse cellular Activities) family of ATPases that hydrolyze ATP and use the resulting energy to extract polyubiquitinated target proteins from membranes, organelles, and large protein assemblies and delivered them to proteasomal degradation^13,14,15,16. As a central component of the Ubiquitin Proteasome System (UPS), VCP/p97 plays a critical role in cellular proteostasis^13,17,18. Indeed, VCP/p97 is involved in the endoplasmic reticulum (ER)-associated protein degradation^15,19, the mitochondrion-associated protein degradation²⁰, ribosomal quality control²¹, the extraction of chromatin-bound proteins²² or of damaged lysosomes by autophagy²³, genome stability²⁴, and stress granules clearance²⁵. Mutations in this well-conserved protein can lead to protein aggregation and have been linked to several diseases, including neurodegenerative and muscular disorders and cancer^26,27,28.

Each monomer of the hexameric VCP/p97 protein is composed by an N-terminal domain followed by two tandem ATPase domains (D1 and D2) separated by a short linker, and an unstructured C-terminal tail²⁹. The N-terminal domain can be further subdivided into two subdomains, Nn (15–95 aa) and Nc (104–175 aa). This structure allows the association of VCP with a large variety of cofactors/adaptors which determine substrate specificity, target the ATPase to different cellular locations, or modify the ubiquitin chain attached to the substrate^30,31,32. So far, about 30–40 cofactors have been identified in mammals but their exact functions are still poorly understood. Whether they have a substrate-recruiting, processing or regulatory function, most cofactors interact with the Nn or Nc subdomains of VCP via a small number of conserved binding modules, while a lower number binds to the unstructured C‐terminal tail formed by the last 7 amino acids^30,31,32. In mammals, most VCP cofactors contain the ubiquitin regulatory X domain (UBX) or UBX-like (UBXL) with similar three-dimensional structure described for ubiquitin. The UBX module interacts with the Nn-Nc cleft of the VCP through the Rx(3)FPR motif. Proteins such as UBXD1 to UBXD6, UBXD9 and UBXD11 contain only a UBX domain. The UBA (ubiquitin associated)-UBX cofactors, such as UBXD7, UBXD8 (FAF2), UBXD10 (p47), UBXD12 (FAF1) and UBXD13 also accommodate an UBA domain that is fundamental for interacting with ubiquitinated substrates^16,33. Cofactors such as p47 harbor, in addition to the UBX and UBA domains important for their function in the UPS, a SHP (BS1, binding segment 1) motif as another site for interaction with the Nc subdomain of VCP^31,32. Cofactors harboring either a VIM (VCP-interacting motif) or VBM (VCP-binding motif) motif also interact with the same hydrophobic pocket of the N-domain³². One of the most studied VCP cofactor, the heterodimer UFD1-NPL4 (UN), interacts with VCP to form the VCP-UFD1-NPL4 complex which extracts polyubiquitinated proteins from membranes and macromolecular complexes and is involved in a series of biological processes, including ER-associated degradation (ERAD)³⁴. Few cofactors have been reported to interact with the C-terminus of VCP. These harbor a PUB (PNGase/UBA or UBX-containing proteins) or a PUL (PLAP, Ufd3p, and Lub1p) domain which forms a hydrophobic pocket for interactions with the C-terminal tail of VCP³⁵ following association of key amino acids such as Leu⁸⁰⁴ and the aromatic side chain of the penultimate tyrosine⁸⁰⁵ residue^30,31,32.

Our initial studies on the ubiquitin selective chaperone VCP/p97 in Leishmania (LiVCP) demonstrated its essential role in the parasite intracellular development and survival under heat stress¹⁰. In this study, we provide novel insights into the LiVCP interaction network. A series of immunoprecipitation experiments coupled to liquid chromatography-tandem mass spectrometry analysis were used to identify the major interacting partners of LiVCP. These studies uncovered p47, UFD1, NPL4, FAF2 and PUB1 as the core LiVCP cofactors. Network proteomics for each cofactor confirmed close partnership with LiVCP and revealed the presence of multiple LiVCP complexes in Leishmania, including the well-characterized LiVCP-LiUFD1-LiNPL4 complex. Gene Ontology analysis of each cofactor proteome combined with digitonin fractionation and immunofluorescence studies support cofactor subcellular compartmentalization. Furthermore, in silico models based on 3D homology modeling and protein–protein docking predicted that, with the exception of NPL4, conserved binding modules within key Leishmania VCP cofactors interact with specific binding sites in the hexameric LiVCP protein, as described for their mammalian orthologs. Altogether, these results allowed us to build the Leishmania VCP protein network, the first characterized in parasitic protozoa.

Results

Identification of the Leishmania VCP/p97 cofactors and core proteome

VCP/p97 is a hexameric protein that can interact with a large number of protein cofactors through its N-terminal and C-terminal domains²⁷. These interactions are key for its activity and functional diversity. This study aimed to identify the Leishmania VCP interactome based on the human VCP/p97 network from the BioGrid database (Supplementary Table S1) as well as on protein–protein interaction experiments. According to the e-value similarity accessed by protein BLAST (blastP), most proteins from the human VCP network have homologs in Leishmania (Supplementary Fig. S1).

Seeking for the identification of Leishmania VCP cofactors, we carried out a series of immunoprecipitation (IP) experiments with either C- or N-terminally HA-tagged Leishmania infantum VCP (LiVCP; LinJ.36.1420)¹⁰ followed by LC–MS/MS, database searching, and peptide identification. To allow VCP expression from its endogenous locus, we replaced one LiVCP genomic copy by a HA-epitope tagged LiVCP (LiVCP-HA) (Fig. 1A). Both episomal and integrated LiVCP-HA versions were expressed at levels comparable to the endogenous VCP protein (Fig. 1B) and yielded similar IP results. From seven independent IP-MS/MS experiments (see Methods), 218 proteins were initially identified as potential LiVCP interacting partners (Supplementary Table S2). To decrease the number of false positives in the LiVCP network building, we applied a stringent filter. First, we calculated the average number of peptides for each protein in all seven IPs and then we excluded proteins also found in five independent IP-MS/MS studies conducted with HA-tagged proteins unrelated to the VCP complex (Fig. 1C and Supplementary Table S2). From this analysis, 24 proteins were selected to specifically associate with LiVCP. Among those, 15 proteins with an average of exclusive unique peptide count (EUPC) ≥ 2.0 were classified as the LiVCP core partners (Fig. 1D and Supplementary Table S2). These share conserved domains with known VCP cofactors in other eukaryotes, such as the p47 (Shp1) UBX/UBA- and SEP-containing protein (LinJ.22.0200), the UBX-containing protein FAF (Fas-associated factor) shown a higher homology to the human FAF2 protein (UBXD8 or ETEA; LinJ.35.1960), the ubiquitin fusion degradation protein 1 (UFD1; LinJ.36.6780), the nuclear protein localization 4 (NLP4; LinJ.25.1320) known to form a heterodimer with UFD1³⁴, an ubiquitin associated UBA/TS-N domain protein (LinJ.24.1650) with an identified ER membrane signal peptide, and two PUB (PNGase/UBA or UBX) domain containing proteins (LinJ.11.0920 and LinJ.09.1060). In addition, the LiVCP proteome core includes the serine/threonine phosphatase type 1 (PP1) (LinJ.34.0900), the PP1 regulator-like protein (LinJ.05.1200) whose human homolog SDS22 is known to interact with VCP³⁶, three mitochondrial proteins—a stomatin-like protein (LinJ.05.1040), an ATP-dependent zinc metallopeptidase (LinJ.36.2850) and the AAA + FtsH protease (LinJ.36.2850), a tetratricopeptide repeat protein part of the ER membrane protein complex subunit 2 (LinJ.17.0230) and three hypothetical proteins (LinJ.36.5080, LinJ.03.0250, LinJ.15.1570) (Fig. 1D) with some similarity to the yeast nuclear envelope protein Nsp1-like C-terminal region, syntaxin-like domain, and putative nuclear jumonji-like domain, respectively.

Apart from the above core partners, LiVCP co-immunoprecipitated heat shock proteins, chaperonins, T-complex proteins, mitochondrial integrity and stress response proteins, translation factors and ribosomal proteins, components of the trypanothione and peroxidase systems, RNA-binding proteins, and proteasome subunits (Supplementary Table S2) in line with its function in a broad array of ubiquitin-dependent protein quality control pathways^13,14,15,16.

‘Network proteomics’ analysis to identify interacting partners of the core LiVCP cofactors and associations between cofactor-bound proteins

The interaction of p47, UFD1, NPL4, FAF2 and PUB1 with the Leishmania VCP ortholog was further confirmed by inverse co-immunoprecipitation studies. C- or N- terminally HA-tagged Lip47, LiNPL4, LiUFD1, LiFAF2, or LiPUB1 proteins cloned into vector pSP \(\alpha\) ZEO \(\alpha\) were transfected and stably expressed in L. infantum promastigotes (Supplementary Fig. S2A). Immunoprecipitation of these HA-tagged cofactor versions using an anti-HA antibody followed by western blotting with a specific anti-TbVCP antibody^10,37 confirmed their association with LiVCP (Fig. 2A). The co-immunoprecipitation of LiUFD1, LiNPL4, Lip47, LiFAF2 and LiPUB1 with LiVCP (Fig. 1D and Table 1) and the detection of LiVCP in LiUFD1, LiNPL4, Lip47, LiFAF2 and LiPUB1 immunoprecipitates by western blotting (Fig. 2A) and mass spectrometry (Fig. 2B, Table 1, Supplementary Table S2) confirmed their close partnership.

Table 1 Proteins specifically associated with one or more Leishmania LiVCP cofactors as determined by immunoprecipitation and LC–MS/MS studies.

Full size table

As done for LiVCP, we carried out IP-MS/MS studies with five unrelated proteins to VCP complexes (average EUPC > 3.6; LiVCP threshold) to filter out non-specific LiVCP cofactor partners (Fig. 3A and Supplementary Table S2). The remaining proteins that co-immunoprecipitated with Lip47 (145), or LiFAF2 (164), or LiUFD1 (46) and or LiPUB1 (98) can be considered as putative cofactor interacting partners (Fig. 3A, Table 1 and Supplementary Table S2).

Lip47 co-immunoprecipitated LiPUB1, the serine/threonine protein phosphatase 1 (PP1) catalytic subunit beta (LinJ.28.0730), a PP1 regulator-like protein that is homologous to the yeast SDS22 protein (LinJ.05.1200), and the PP1 phosphatase inhibitor that is homologous to the yeast Ypi1 protein (LinJ.07.0840) (Table 1). In Saccharomyces cerevisiae, these three proteins form a ternary complex that is important for the nuclear localization of PP1 and whose assembly and quality control requires Cdc48 and its adaptor p47³⁸.

As reported in other eukaryotes³⁴, the Leishmania LiUFD1 protein complexes with NPL4 to form the heterodimer cofactor UFD1-NPL4 but also associates with LiFAF2 (Table 1). Complex formation between VCP-NPL4-UFD1, FAF1 and polyubiquitinated proteins was shown previously to promote ER-associated degradation³⁹. Other proteins only associated with the LiUFD1 proteome include a mitochondrial serine carboxypeptidase (CBP1; LinJ.18.0450), a phenylalanine-4-hydroxylase (LinJ.28.1390), peroxin PEX12 (LinJ.19.1240) and three hypothetical conserved proteins (LinJ.03.0250, LinJ.29.2300, LinJ.12.0550) (Table 1 and Supplementary Table S2). Interestingly, the hypothetical protein LinJ.03.0250 was also found in LiVCP immunoprecipitates (Fig. 1C), and some of the other LiUFD1 interacting proteins have homologs known to be part of the VCP network in other systems (see Discussion).

Proteins solely detected in LiFAF2 pull-down include a tetratricopeptide repeat containing protein of the ER membrane protein complex (LinJ.17.0230) also found in LiVCP immunoprecipitates (Fig. 1C), several peroxisomal/glycosomal proteins that are homologs of the peroxins PEX2 (LinJ.25.2330), PEX10 (LinJ.25.2400) and PEX11 (LinJ.35.3740), two fatty acid elongases (ELO1: LinJ.14.0680 and ELO3: LinJ.14.0760), a cell differentiation protein-like (LinJ.34.4180), and hypothetical protein LinJ.36.5360 (Table 1).

The LiPUB1 cofactor co-immunoprecipitated a serine palmitoyltransferase 1-like protein (LinJ.34.3530; SPT1), also found in the LiUFD1 proteome (Table 1). Serine palmitoyltransferase catalyzes the first and rate-limiting step in sphingolipid (ceramide) biosynthesis and has been associated with the resistance to heat stress and apoptosis^40,41.

Interestingly, several LiVCP cofactor-associated proteins are common to more than two cofactors (see Table 1). For example, Lip47, LiFAF2 and LiPUB1 co-immunoprecipitated the tubulin polymerization-promoting protein TPPP/p25-alpha (LinJ.34.1620) that stabilizes microtubules⁴² and also protects against abnormal forms of prion proteins⁴³, as well as the root hair defective 3 GTP-binding protein (RHD3) (LinJ.32.0380) that is analogous to the mammalian atlastin GTPases involved in shaping ER tubules⁴⁴. An ADF/cofilin factor (LinJ.29.0520) of the family of actin remodeling proteins⁴⁵ co-immunoprecipitated with both Lip47 and LiFAF2. The ribosomal protein S33 (LinJ.26.1610) and the hypothetical protein LinJ.33.1130 co-immunoprecipitated with LiFAF2 and LiPUB1. The V-type proton ATPase subunit D (LinJ.05.1140), a multi-subunit membrane protein complex that is evolutionarily related to F-type adenosine triphosphate synthases and A-ATP synthases⁴⁶, co-immunoprecipitated with Lip47 and LiUFD1. The LiUFD1, LiFAF2 and LiPUB1 cofactors co-immunoprecipitated the trypanosomatid functional analog of Tom40 (ATOM40; LinJ.35.4920), which is the central pore of the TOM complex involved in the import of mitochondrial proteins⁴⁷. Finally, all LiVCP core cofactors co-immunoprecipitated a fatty acid elongase (ELO2) (LinJ.14.0700).

General features of the LiVCP core cofactors

Proteins specifically co-immunoprecipitated with LiUFD1, Lip47, LiFAF2, or LiPUB1 were submitted to Gene Ontology – cellular component (GO-CC) enrichment analysis using the tool provided by TriTrypDB (Fig. 3B and Supplementary Table S3). An enrichment of a 19-fold for vacuolar proteins was seen in the LiUFD1 proteome. Nuclear proteins were exclusively enriched within the Lip47 proteome and endoplasmic reticulum-related proteins were enriched only within the LiFAF2 and LiPUB1 proteomes.

Molecular function (MF) and biological process (BP) analyses were also done aside comparison with the LiVCP proteome (Supplementary Table S3). Globally, the molecular function analysis predicted proteins with translation factor activity and structural constituents of the ribosome, RNA-binding activity, structural molecule activity and peptidase activity. ATPase and ligase activities were exclusively enriched within the LiFAF2 proteome while transmembrane transporter activity was only associated with the LiUFD1 proteome.

The biological process analysis showed that cofactor-associated proteins were mostly involved in translation, protein targeting and folding, and several metabolic processes. Protein folding and tRNA metabolic processes were found only associated with the LiFAF2 proteome while protein targeting and mitotic cell cycle were enriched in the LiPUB1 proteome (Supplementary Table S3). Overall, Gene Ontology analysis of each proteome indicated specific compartment-association for each cofactor.

Subcellular localization of the LiVCP core cofactors

To determine the subcellular localization of the core LiVCP cofactors, we carried out digitonin fractionation and indirect immunofluorescence studies. As a central player to the endoplasmic reticulum (ER)-associated protein degradation^19,48 and the translocation of damaged mitochondrial proteins from the outer mitochondrial membrane (OMM) into the cytosol^20,49, VCP has been found associated with both ER and OMM fractions, similarly to what we have described previously for the Leishmania LiVCP¹⁰.

First, we treated Leishmania parasites with increasing concentrations of digitonin (20 μM-10 mM) and carried out western blotting on the different cellular sub-fractions using an anti-HA antibody (all cofactors were HA-epitope tagged). Our results indicate an association of LiFAF2 and partly of LiPUB1 proteins with the organellar fraction and an enrichment of LiUFD1, Lip47 and LiNPL4 proteins with the cytosolic fractions (Fig. 4A). Immunofluorescence studies using an antibody directed against the ER BiP protein confirmed that LiFAF2 and partly LiPUB1 co-localize to endoplasmic reticulum (Fig. 4B, 4C). No co-localization was found with the mitochondrion (data not shown). Immunofluorescence studies to detect Lip47 demonstrated a partial co-localization with the histone H3 nuclear marker (Fig. 4D), as also suggested by GO analysis (Fig. 3B).

Predicted molecular interactions between the conserved domains of LiVCP cofactors and the Leishmania VCP protein based on 3D homology modeling and protein–protein docking

It has been shown previously that the VCP/p97/Cdc48 hexamer can bind to its various cofactors through the UBX or PUB domains or a ubiquitin-like fold or through one of the linear binding motifs such as SHP³². The L. infantum LiVCP encodes a protein of 784 amino acids that is highly conserved among its eukaryotic orthologs (75% aa identity with the human VCP/p97 protein)¹⁰ and harbors all the characteristic domains of VCP orthologs (Fig. 5A, top). Based on sequence similarity and conservation to mammalian VCP cofactor orthologs (Supplementary Fig. S1) and on the EUPC for each cofactor in LiVCP immunoprecipitates (Fig. 1), we selected Lip47, LiUFD1, LiNPL4, LiFAF2, and LiPUB1 as the core LiVCP cofactors for further investigation. Multiple sequence alignments of these LiVCP cofactors along with mammalian, yeast, trypanosomatid and non-trypanosomatid species helped us to generate phylogenetic trees revealing that Lip47, LiFAF2, LiUFD1, LiNPL4 and LiPUB1 are evolutionary distant from other eukaryotes but they harbor binding modules/motifs that are conserved and could represent specific domains for interaction with LiVCP (Supplementary Figs. S3-S7).

To investigate whether LiVCP-cofactor interactions identified by immunoprecipitation studies take place within the previously predicted binding sites in the hexameric VCP protein^30,32 and the conserved binding modules in Lip47, LiFAF2, LiUFD1, LiNPL4 and LiPUB1, we constructed 3D models by homology modeling and a protein–protein docking approach. 3D homology models are helpful in refining protein–protein interaction predictions that have been based on a sequence match alone as interface binding is more directly determined by the structure of the binding site rather than its sequence. The LiVCP homohexamer 3D molecular structure was obtained through homology modeling by superposition with the H. sapiens p97 homohexamer (PDBid: 5C18) template (Fig. 5A, bottom).

The Lip47 protein presents the same domain composition (UBA, SEP and UBX) than its human ortholog (Fig. 5B, upper). Similarly to the human p47, Lip47 harbors the sequence GMPP in the UBX domain (Supplementary Fig. S8) that docks in silico into the Nn-Nc pocket of LiVCP (Fig. 5B and Supplementary Fig. S9)⁵⁰. Although Lip47 shares only 25% amino acid identity with its human ortholog, it has 41% sequence similarity and 73% sequence coverage and contains the two SHP motifs (SHP1 and SHP2) (Supplementary Fig. S8) that together with the UBX domain are known to be key for the interaction with VCP³¹. The SHP site is typically characterized by the consensus sequence FxGxGx₂h that was recently summarized as h(x)₁₋₂F/W(x)₀₋₁GxGx₂L (h, hydrophobic residue; x, any amino acid)³² and in Lip47, SHP1 and SHP2 sites, FYGRGQRL and FQGHGHRL, respectively are conserved (Supplementary Fig. S8). In addition, the Ramachandran plot showed that the amino acid residues of the Lip47 3D homology model are found in most favoured (87%) and additional allowed regions (8.7%) (Supplementary Table S4), which makes structure predictions reliable.

The LiFAF2 protein interacts with LiVCP through the GFPP motif in its UBX C-terminal domain as predicted by 3D homology modeling (Fig. 5C, Supplementary Fig. S10) and protein–protein docking upon superposition of the available structure of the human ⁴⁰GYPP⁴³ motif in the ovarian tumor domain-containing protein 1 (OTU1) and the homologous part within the Leishmania FAF2 protein (Supplementary Fig. S11). Surprisingly, LiFAF2 lacks the ubiquitin-associated (UBA) domain that is present in the human FAF1 and FAF2 proteins and is fundamental for interacting with ubiquitinated substrates⁵¹.

UFD1 is known to assemble with NPL4 to form the heterodimer UFD1/NPL4 (U/N), one of the most important p97/VCP cofactors, that recognizes polyubiquitinated substrates and together with VCP extracts them from organellar membranes or macromolecular complexes^52,53. U/N binds to the N-terminal domain of VCP via the ubiquitin-like domain (UBL) of NPL4 and the SHP box of UFD1³². The Leishmania LiUFD1 protein also contains the UBA domain and an UT6 region that accommodates the sequences QPTFAGAGRTL and RLKALGGGGRS corresponding to the SHP1 and SHP2 sites, respectively (Fig. 5D, top and Supplementary Fig. S12). 3D homology modeling predicts binding of LiUFD1 to LiVCP via its SHP1 site (Fig. 5D, bottom). Furthermore, docking essays propose that the SHP1 motif of LiUFD1 (reversed comparatively to the human SHP1) interacts with the same surface as in its human ortholog using amino acid residues Phe273, Arg278 and Leu280 (Phe228, Arg234 and Leu235 in human Ufd1) (Fig. 5D bottom and Supplementary Fig. S13).

In contrast to its eukaryotic orthologs, the Leishmania NPL4 lacks the N-terminal ubiquitin regulatory X (UBX)-like domain bound to the N-domain of Cdc48 hexamer, as well as the two Zn²⁺-finger domains important for anchoring the adjacent Mpr1/Pad1 N-terminal (MPN) domain to the top of the D1 ATPase ring³⁴. Interestingly, protein–protein docking simulations showed that despite the absence of the UBX-like domain, LiNPL4 seems to interact with the N-terminus of LiVCP through its C-terminal GMPP motif (aa 350–353) (Supplementary Figs. S14, S15). Similarly to other eukaryotes³⁴, the U/N heterodimer in Leishmania also recognizes polyubiquitinated substrates as shown by LiNPL4 and LiUFD1 IPs followed by western blotting (Supplementary Fig. S16).

A representative member of the PUB (PNGase/UBA or UBX-containing) domain proteins in Leishmania, LiPUB1, which has no homolog in humans, contains a conserved region (Supplementary Fig. S17) that is predicted by 3D homology modeling (Fig. 5E) and protein docking (Supplementary Fig. S18) to interact with the last five amino acids ⁷⁸⁰DDLYS⁷⁸⁴ of the LiVCP C-terminus, similarly to other PUB domain proteins ⁵⁴.

Altogether, despite the evolutionary distance of LiVCP cofactors from their mammalian orthologs, in silico models based on structural data from the human orthologs using 3D homology modeling and protein–protein docking indicated that the conserved binding modules of Leishmania VCP core cofactors (except LiNPL4) interact with specific binding sites in the hexameric LiVCP, similarly to their mammalian orthologs.

The first trypanosomatid VCP interaction network

The resulting datasets from LiVCP, Lip47, LiUFD1, LiFAF2 and LiPUB1 IP-MS/MS studies were mined to identify interacting partners that are specific to each LiVCP cofactor as well as partners that are shared among multiple cofactors and LiVCP complexes (Fig. 6A) and allowed us to build the first LiVCP interaction network (Fig. 6B). To decrease the number of false positives, we excluded proteins that were co-immunoprecipitated with unrelated HA-tagged proteins (average of EUPC = 0.0). From the total number of proteins co-immunoprecipitated with Lip47, LiUFD1, LiFAF2, and LiPUB1 (Fig. 3A) only 10, 17, 23 and 9, respectively together with 24 proteins specifically associated to LiVCP (Fig. 1^,Table 1 and Supplementary Table S2) were considered to build the topology of LiVCP network (83 proteins in total, 47 shown in Fig. 6B). The list of proteins and their intersections are detailed in Supplementary Table S5 whereas the complete list of interacting proteins is presented in Supplementary Table S2.

In addition to the known cofactors, eight proteins were exclusively associated with the LiVCP proteome and might also be considered as cofactors of the Leishmania VCP protein. These include another PUB domain protein (PUB2) (LinJ.11.0920), an OTU1 (ovarian tumor domain-containing protein 1-like cysteine protease (LinJ.36.6280) that is homologous to the S. cerevisiae deubiquitylation enzyme OTU1 shown to interact with VCP⁵⁵, a protein present in the outer mitochondrial membrane (LinJ.29.2220), a P-type H + -ATPase (LinJ.18.1510), a microtubule-associated protein (LinJ.26.1950), a member of the FYVE zinc finger proteins (LinJ.36.2570) that serve as regulators of endocytic membrane trafficking and receptor signaling⁵⁶, a type 1 protein serine/threonine phosphatase (PP1) (LinJ.34.0900) and a Leishmania specific hypothetical protein (LinJ.36.5080) (Fig. 6B and Supplementary Table S5).

Our analysis revealed that the LiUFD1 and LiFAF2 proteomes share five proteins in common with LiVCP. These include the mitochondrial stomatin-like protein 2 (SPL-2) (EUPC > 20), the membrane-integrated mitochondrial AAA/FtsH protease⁵⁷, an UBA domain containing protein (LinJ.24.1650), and hypothetical conserved proteins LinJ.15.1570 and LinJ.36.4740 (Table 1, Fig. 6B). LiVCP and Lip47 mutually associate with the serine/threonine protein PP1 phosphatase catalytic subunit, the PP1 phosphatase inhibitor Ypi1, and the SDS22 (EUPC = 20) PP1 regulator-like protein (Table 1, Fig. 6B and Supplementary Table S5). LiVCP and LiFAF2 mutually co-immunoprecipitate the tetratricopeptide repeat protein (LinJ.17.0230) and an uncharacterized protein family (LinJ.07.0450), both subunits of the ER membrane protein complex (Table 1, Fig. 6B and Supplementary Table S5). LiVCP and LiUFD1 mutually interact with the hypothetical protein LinJ.03.0250 (Table 1, Fig. 6B and Supplementary Table S5). Specific interactions between cofactor-associated partners that do not involve an association with LiVCP are described in detail in the ‘network proteomics’ section (see also Table 1 and Fig. 6B).

Overall, using combined datasets from multiple IP/MS–MS studies for LiVCP and its main cofactors, we unveiled the first Leishmania LiVCP interactome. Many of the LiVCP interactors have homologs that are known to interact with VCP in other eukaryotic systems but others do not and may be relevant to study further as part of distinct Leishmania VCP complexes.

Discussion

In this study, we have characterized the valosin‐containing protein (VCP) interaction network, the first in parasitic protozoa. We have employed a series of co-immunoprecipitation and mass spectrometry analyses coupled with in silico models that allowed us to identify the Leishmania VCP proteome with its major cofactors and their interacting partners, as well as, to predict molecular interactions between conserved domains within these cofactors and specific binding sites in the hexameric LiVCP. Our data support several similarities but also important differences between the Leishmania VCP protein network and VCP complexes characterized in other eukaryotes.

Most of the known classes of VCP cofactors in other eukaryotes have orthologs in Leishmania. However, cofactors harboring the VIM (VCP-interacting motif)/VBM (VCP-binding motif) motifs⁵⁸ were not found in any of our immunoprecipitation experiments, and with the exception of the ERAD-associated E3 ubiquitin-protein ligase HRD1 (LinJ.15.1460) no homologs of this class of proteins were depicted in the Leishmania genome. While LiVCP is highly conserved among different eukaryotic organisms and harbors all the characteristic domains of the human p97/VCP ortholog¹⁰, most of the major LiVCP cofactors are phylogenetically distant from their eukaryotic orthologs. However, despite their evolutionary distance from yeast and mammalian orthologs, in silico models based on 3D homology modeling and protein–protein docking indicated that the conserved binding modules of Leishmania VCP cofactors interact with specific binding sites in the hexameric LiVCP, similarly to their eukaryotic orthologs. This is the case for Lip47 and LiFAF2 that bind the Nn-Nc pocket of LiVCP through the sequence GMPP/GFPP in their UBX domain. Surprisingly, LiFAF2 lacks the UBA domain and theoretically should have lost the ability of binding ubiquitinated substrates⁵⁹. Similarly to its yeast ortrholog³⁴, LiUFD1 interacts with the N-terminus of LiVCP through its conserved SHP motif. LiPUB1 while has no human homolog yet interacts with the C-terminal region of LiVCP, as described for the human VCP-PUB complex.

One of the important differences unveiled by our study concerns LiNPL4, which lacks the UBX-like domain and the two Zn²⁺-finger motifs shown to bind VCP. Indeed, recent studies on the structure of the Cdc48-Ufd1-Npl4 complex from the thermophilic fungus Chaetomium thermophilum demonstrated that Npl4 interacts with the Cdc48 N-terminal region through its UBX-like domain and uses the Zn²⁺-finger motifs to anchor its MPN domain to the top of the D1 ATPase ring³⁴. On the other hand, Ufd1 interacts with Npl4 to form the Ufd1-Npl4 heterodimer through a short segment of its UT6 domain³⁴ which is also conserved in the Leishmania Ufd1 ortholog. Our 3D homology modeling and docking experiments predicted binding of LiNPL4 to LiVCP through its C-terminus GMPP motif. All NPL4 orthologs of the genus Leishmania, Leptomonas and Phytomonas harbor the GMPP motif and a variant of this motif, GM-[EDS]-PP, is present in Trypanosoma species. This unique feature in Trypanosomatidae paves the way for the design of inhibitors specifically targeting NPL4 binding to VCP. Ufd1-Npl4 and p47 are substrate-recruiting cofactors shown to bind VCP in a mutually exclusive manner as they compete for the same binding modules^30,31. This seems also to be the case in Leishmania. Lip47 was neither found in the LiUFD1 proteome nor LiUFD1 in the Lip47 pull-down. Moreover, they do not share common interacting partners, except for the V-type proton ATPase subunit D.

Our analysis led us to identify the first PUB domain proteins in Leishmania and to unveil LiPUB1 as one of the major LiVCP cofactors interacting with the C-terminal region of LiVCP. Furthermore, new prospects were opened with the yet non-studied PUB domain protein LiPUB2 identified here as a putative LiVCP cofactor. In addition, a third UBX- and PUB domain-containing protein (LinJ.36.0140; LiPUB3) was retrieved by searching the L. infantum genome database. PUB domain proteins known to bind to the C-terminus of the VCP hexamer have been associated with autophagy of damaged lysosomes²³ but the physiological significance of these interactions remains to be determined. Here, we found that a serine palmitoyltransferase-like protein was associated solely with the LiPUB1 proteome. Interestingly, a homolog of this protein in yeast is required for resistance to heat shock and plays an essential role in the removal or refolding of denatured or aggregated cytoplasmic proteins⁶⁰. We have reported recently that LiVCP is essential for the parasite survival under heat stress¹⁰, and PUB proteins with the help of a serine palmitoyltransferase may contribute to this process.

Interestingly, our study revealed new LiVCP interacting partners exclusively associated with the LiVCP proteome that might function as LiVCP cofactors. These include a PUB domain protein (LiPUB2), an outer mitochondrial membrane protein, a P-type H + -ATPase with homology to fungal and plant proton pumps⁶¹, a FYVE zinc-finger protein known to bind phosphatidylinositol 3-phosphate in membranes of endocytic vesicles that regulate membrane trafficking and receptor signaling⁵⁶, a microtubule-associated protein, and several hypothetical conserved proteins that may be part of distinct VCP-complexes. LiVCP, and also Lip47, associates with the type 1 protein serine/threonine phosphatase (PP1) complex consisting of the PP1 catalytic subunit Glc7/PP1-B, the SDS22 regulator-like protein and the protein phosphatase PP1 inhibitor YPI1. In S. cerevisiae, nuclear localization of Glc7 requires Sds22 and Ypi1⁶². It has been shown recently that nuclear PP1 activity is positively regulated by the AAA-ATPase Cdc48 and its cofactor Shp1 (p47)⁶³ to promote the assembly of the Glc7-Sds22-Ypi1 PP1 complex and to ensure its quality control³⁸. Interestingly, here we found that Lip47 interacts with a large number of nuclear proteins and that is partly localized to the nucleus. From an evolutionary point of view, it is interesting that the interaction of LiVCP with Lip47 may regulate the assembly of the Glc7-Sds22-Ypi1 complex like is the case in yeast. LiVCP was found also associated, although not in all immunoprecipitates, with substrate-processing cofactors like the thioesterase ovarian tumor domain-containing protein 1 (OTU1), a deubiquitinating enzyme involved in ERAD through the interaction of its UBX-like (UBXL) domain with the N-terminus of Cdc48⁶⁴. Although it is yet unclear how the polyubiquitinated substrates are released from the p97/VCP/Cdc48 complex and passed on to the proteasome⁶⁵, OTU1 can be the deubiquitinase involved in this process as its UBXL domain interacts with VCP⁵⁵. Although the Leishmania OTU1 ortholog does not harbor a well-defined UBXL domain, interestingly the ³⁹GYPP⁴² loop of UBXL in S. cerevisiae shown not only to be critical for the interaction with VCP but also for its role in the ERAD pathway⁵⁵ it is conserved in Leishmania (⁴⁹GFPP⁵²).

Another novel finding here is the association of the Leishmania VCP and also of its cofactors LiFAF2 and LiUFD1 with a stomatin-like protein 2 (SLP-2). Stomatins are members of the SPFH (stomatin, prohibitin, flotillin, HflC/K) superfamily that localize to the mitochondrial inner membrane scaffolding for the spatial organization of inner membrane proteases regulating mitochondrial dynamics, quality control, and cell survival⁶⁶. Accordingly, our data support the association of LiUFD1 with transmembrane transport and peptidase activity proteins. It is possible that LiVCP associates with SLP-2 through UFD1, which also interacts with FAF2. Also present in the LiVCP proteome and associated with both LiFAF2 and LiUFD1 cofactors is the mitochondrial ATP-dependent AAA + protease FtsH whose proteolytic and chaperone-like activity is crucial to the protein degradation protein quality control of mitochondrial and chloroplast membranes⁶⁷. This suggests a new model for membrane protein degradation mediated by ATP-dependent proteolytic systems⁵⁷.

Our data support a subcellular compartmentalization for the key LiVCP cofactors. LiFAF2 and LiPUB1 are associated with organelles, LiFAF2 most likely with endoplasmic reticulum (ER), Lip47 is partially localized to the nucleus, LiUFD1 is possibly associated with cytosolic vacuoles, and NPL4 is enriched in the cytoplasm. Interestingly, LiFAF2 is associated with the peroxisomal biogenesis factors PEX2, PEX10 and PEX11. Similarly to other eukaryotes⁶⁸, recent data in trypanosomatids support de novo biogenesis of peroxisomes (glycosomes) from the ER⁶⁹. In higher eukaryotes PEX2, PEX10 and PEX12 are part of the peroxisomal E3 ubiquitin ligase complex required for pexophagy, a pathway to degrade ubiquitinated peroxisomes that involves an AAA ATPase complex with a striking similarity to p97⁷⁰. Glycosome turnover in Leishmania is mediated by autophagy⁷¹ and the VCP/p97 quality control system, possibly through its FAF2 cofactor, may contribute to the control of glycosome homeostasis and turnover in these parasites. LiFAF2 also associates with two fatty acid elongases of the ELO GNS1/SUR4 family involved in the membrane-bound fatty acid chain elongation⁷². Interestingly, an ELO2 fatty acid elongase was found in the proteome of all four LiVCP cofactors (p47, UFD1 FAF2, PUB1). In trypanosomatids, the fatty acid elongation pathway occurs in the membrane of the ER⁷³ and this could explain its association with components of the ERAD pathway.

In summary, this study allowed us to build the first VCP protein interaction network in trypanosomatids through the identification of known and novel interacting partners potentially associated with distinct VCP complexes. Our proteomics datasets identified biologically relevant functions for the Leishmania VCP cofactors and provided an important resource for further investigation of VCP function in several cellular processes related to protein quality control in these parasites.

Methods

Parasite strains, plasmid constructs and transfections

Leishmania infantum MHOM/MA/67/ITMAP-263 was used in this study. L. infantum promastigotes were cultured in SDM-79 medium supplemented with 10% heat-inactivated FCS (Multicell Wisent Inc., Canada) and 5 μg/ml hemin at pH 7.0 and 25 °C. The Lip47 (LinJ.22.0200/LINF_220008200), LiFAF2 (LinJ.35.1960/LINF_350024700), LiUFD1 (LinJ.36.6780/LINF_360076400), LiNPL4 (LinJ.25.1320/ LINF_250019000), and LiPUB1 (LinJ.09.1060/LINF_090016300) genes were amplified and cloned into pSP72αZEOα. An HA epitope tag was added either at their N-or C-terminus. Primers used in this study are shown in Supplementary Table S6. The generated plasmids were independently transfected into L. infantum promastigotes. Purified plasmid DNA (10–20 μg, Qiagen Plasmid Mini Prep Kit, Toronto, Ontario, Canada) or linearized fragments (10–20 μg for the targeting cassette 5′flank‐αZEOα‐VCP^HA‐3′flank from¹⁰ were transfected into Leishmania by electroporation as described previously⁷⁴. Stable transfectants were selected and cultured with 0.6 mg/ml zeocin (Sigma).

Protein lysate preparations and western blots

Western blots were performed following standard procedures. The anti-mouse HA tag monoclonal antibody (1:3,000; ABM), the anti-mouse HSP70 (cytosolic) antibody (1:400, Acris), the anti-rabbit HSP70 (mitochondrial) antibody (1:2000, kindly provided by Dr. Osvaldo de Melo Neto, Recife, Brazil), and the anti-mouse T. brucei (Tb)VCP antibody (1:5,000;³⁷ kindly provided by Dr. James D. Bangs (Department of Microbiology & Immunology, Jacobs School of Medicine & Biomedical Sciences, University at Buffalo, USA) were used in this study. As a secondary antibody, we used the anti-mouse Horseradish peroxidase (HRP) (Cell Signalling) or the anti‐rabbit‐HRP antibody (GE Healthcare). Blots were visualized by chemoluminescence with Pierce ECL2 western blotting kit (Thermo Scientific). Digitonin fractionation was carried out in the presence of increasing concentrations of digitonin (20 μM to 10 mM) as described previously⁷⁵ and each fraction was analysed by western blot.

Immunofluorescence studies

Immunofluorescence studies were done as described previously^9,10. The anti-mouse HA tag monoclonal antibody (1:1,000; ABM), the anti-mouse H3 Histone 3 antibody (1:500; ABM) and the rabbit polyclonal anti‐T. brucei BiP (kindly provided by Dr. JD Bangs) were used as a primary antibody followed by Alexa Fluor 488 anti-mouse and Alexa Fluor 555 anti-rabbit as secondary antibodies. Nucleus and kinetoplast DNA was stained with DAPI (blue). The cells were observed under a Nikon epifluorescence microscope with a 100X objective and oil immersion. Images acquisition was performed with ImagePro Plus software and ImageJ.

Immunoprecipitation studies

Immunoprecipitation (IP) studies and mass spectrometry analysis were carried out as described previously⁹. Briefly, L. infantum promastigotes expressing HA-tagged protein were lysed, mixed with Pierce anti-HA magnetic beads (Thermo Scientific, Canada) and kept at -20 °C and subjected to mass spectrometry analysis or alternatively resolved in SDS-PAGE, excised, trypsin-digested, and analyzed by mass spectrometry.

Sample preparation and LC–MS/MS analysis

Protein digestion and mass spectrometry analyses were performed by the Proteomics Platform of the CHU de Québec Research Center (Quebec, Qc, Canada) as described previously⁷⁶. Briefly, bands of interest were extracted from gels, placed in 96-well plates and then washed with water. Tryptic digestion was performed on a liquid handling robot (MultiProbe, Perkin Elmer) according to manufacturer’s instructions using the protocol detailed in⁷⁷ with some modifications as suggested in⁷⁸. Proteins were reduced with 10 mM DTT and alkylated with 55 mM iodoacetamide. Iodoacetamide derivative of cysteine was specified as a fixed modification and oxidation of methionine and deamidation of Asparagine and Glutamine were specified as a variable modification. Two missed cleavages were allowed. Trypsin digestion was performed using 126 nM of modified porcine trypsin (Sequencing grade, Promega, Madison, WI) at 37 °C for 18 h. Digestion products were extracted using 1% formic acid, 2% acetonitrile followed by 1% formic acid and 50% acetonitrile. The recovered peptides were pooled, vacuum-centrifuged, dried and then resuspended into 12 µl of 0.1% formic acid, and 5 µl were analyzed by mass spectrometry. Peptide samples were separated by online reversed-phase (RP) nanoscale capillary liquid chromatography (nanoLC) and analyzed by electrospray mass spectrometry (ES MS/MS). The experiments were performed with an Ekspert NanoLC425 (Eksigent) coupled to a 5,600 + mass spectrometer (Sciex, Framingham, MA, USA) equipped with a nanoelectrospray ion source. Peptide separation took place on a self-packed picofrit column (New Objective) with reprosil 3u, 120A C18, 15 cm × 0.075 mm internal diameter, (Dr Maisch). Peptides were eluted with a linear gradient from 5–35% solvent B (acetonitrile, 0.1% formic acid) for 35 min at a flow rate of 300 nL/min. Mass spectra were acquired by a data dependent acquisition mode using Analyst software version 1.7. Each full scan mass spectrum (400 to 1,250 m/z) was followed by collision-induced dissociation of the twenty most intense ions. Dynamic exclusion was set for a period of 12 s and a mass tolerance of 100 ppm.

Database searching

MGF peak list files were created using Protein Pilot version 4.5 software (Sciex). MGF sample files were then analyzed using Mascot (Matrix Science, London, UK; version 2.5.1). Mascot was searched with a fragment ion mass tolerance of 1.0 Da and a parent ion tolerance of 1.0 Da. Scaffold (version Scaffold_4.8.4, Proteome Software Inc., Portland, OR) was used to validate MS/MS based peptide and protein identifications based on the Leishmania Infantum TriTrypDB (version 9.0 released April 2016, 8,589 entries). Peptide identifications were accepted if they could be established at greater than 5.0% probability to achieve an FDR less than 1.0% by the Scaffold Local FDR algorithm. Protein identifications were accepted if they could be established at greater than 99.0% probability to achieve a FDR less than 1.0% and contained at least 2 identified peptides. Protein probabilities were assigned by the Protein Prophet algorithm⁷⁹. Proteins that contained similar peptides and could not be differentiated based on MS/MS analysis alone were grouped to satisfy the principles of parsimony.

3D homology modeling and protein–protein docking

To construct 3D models of L. infantum JPCM5 proteins LiUFD1 (LinJ.36.6780), Lip47 (SEP domain, LinJ.22.0200), LiFAF2 (UBX domain, LinJ.35.1960), LiPUB1 domain (LinJ.09.1060), LiNPL4 (LinJ.25.1320) and LiVCP proteins, we searched for their orthologs in PDB database using BlastP and Delta-Blast. Then, 3D structure models were built using the modelling software MODELLER⁸⁰ based on their homologous structure, PDBid : 5C1B_V, 1S3S_H, 2MX2_A, 2HPL_B, 6CDD_ A and 5C18_D, respectively. The QPTFAGAGRTL SHP1 peptide of LiUFD1 and the DDLYS peptide of LiVCP were modeled using as templates PDBid: 5C1B_V and 2HPL, respectively. The LiVCP hexamer was obtained by superposition with the H. sapiens p97 hexamer (PDBid: 5C18). The quality of the models was assessed by Ramachandran plot analysis through PROCHECK⁸¹. Proteins and peptides of L. infantum were docked into LiVCP using HDOCK⁸² and HPEPDOCK⁸³, respectively. The electrostatic potential surfaces of 3D models and images were generated with PyMOL software (https://pymol.org/).

Multiple alignments and phylogeny

We used the amino acid sequence of each L. infantum JPCM5 protein to search by BlastP and Delta-Blast for close homologs in bacteria, archaea, fungi, plants and animals. The sequences extracted from databases were aligned with Clustal Omega⁸⁴. To establish the phylogenetic relationships between L. infantum proteins and those of prokaryotic and other eukaryotic organisms, the sequences were aligned with Clustal Omega⁸⁴ and a phylogenetic tree was constructed using PhyML⁸⁵. The gene ontology (GO) term enrichment analysis was performed using the tool provided by TriTrypDB (https://tritrypdb.org) with Fisher exact test filtering for false discovery rate (FDR) lower than 0.05. Cellular Component, Molecular Function and Biological Process were carried out separately.

Experimental design and statistical rationale

Filter for LiVCP IP-MS/MS: Seven IP-MS/MS studies were considered for LiVCP (Supplementary Table S2). To select proteins that specifically associate with LiVCP, we calculated the average number of peptides for each protein in all seven experiments, and then excluded all proteins also found in five independent IP-MS/MS studies conducted with HA-tagged proteins unrelated to the VCP complex. From the selected 24 LiVCP specific interacting proteins, 15 with an average of exclusive unique peptide count (EUPC) ≥ 2.0 were classified as the LiVCP core and are presented in Fig. 1C and Supplementary Table S2.

Filter for LiVCP cofactors IP-MS/MS: Two independent experiments were performed for each LiVCP cofactor (Lip47, LiFAF2, LiUFD1 and LiPUB1) and only proteins with an average of exclusive unique peptide count EUPC ≥ 2.0 in both experiments for each cofactor were considered (Supplementary Table S2). To exclude non-specific partners, IP-MS/MS studies with proteins unrelated to LiVCP complexes were carried out and proteins with an average of EUPC > 3.6 (LiVCP threshold) were used to filter out non-specific LiVCP cofactor associated proteins. The remaining proteins co-immunoprecipitated with Lip47, or LiFAF2, or LiUFD1 and or LiPUB1 were considered as putative LiVCP cofactors. Cytoscape v 3.5.1⁸⁶ was used to plot network analyses of all new interactions for LiVCP, Lip47, LiFAF2, LiUFD1 and LiPUB1.

Filter for network plotting: To decrease the number of false positive results in the LiVCP network building, we only show proteins that were not co-immunoprecipitated with all unrelated HA-tagged proteins (average of EUPC = 0.0). From the total number of proteins co-immunoprecipitated with Lip47, or LiUFD1 or LiFAF2 and or LiPUB1, only 10, 17, 23 and 9, respectively were considered together with the 24 LiVCP specific interactors (Fig. 1, Table 1, and Supplementary Table S2) to build the topology of LiVCP network. No statistical analysis was needed.

Data availability

The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE⁸⁷ partner repository with the dataset identifier PXD013731. The Reviewer account details are Username: reviewer11708@ebi.ac.uk, Password: Zm5uR3hc.

Abbreviations

AAA:: ATPases Associated with diverse cellular Activities
ER:: Endoplasmic reticulum
ERAD:: ER-associated degradation
EUPC:: Exclusive unique peptide count
FAF:: Fas-associated factor
FCS:: Fetal calf serum
IP:: Immunoprecipitation
LiVCP:: Leishmania infantum VCP
MPN:: Mpr1, Pad1 N-terminal domain
NPL4:: Nuclear protein localization protein 4
OMM:: Outer mitochondrial membrane
OTU1:: Ovarian tumor domain-containing protein 1
PP1:: Protein phosphatase type 1
PUB:: PNGase/UBA or UBX-containing proteins
PUL:: PLAP, Ufd3p, and Lub1p
SEP:: Shp, eyes-closed, p47
SHP:: BS1, binding segment 1
SPFH:: Stomatin, prohibitin, flotillin, HflC/K
UBA:: Ubiquitin-associated
UBL:: Ubiquitin-like domain
UBX:: Ubiquitin regulatory X
UBXD:: Ubiquitin X domain
UBXL:: Ubiquitin regulatory X-like
UFD1:: Ubiquitin fusion degradation protein 1
UPS:: Ubiquitin Proteasome System
VBM:: VCP-binding motif
VCP:: Valosin-containing protein
VIM:: VCP-interacting motif

References

Cloutier, S. et al. Translational control through eIF2alpha phosphorylation during the leishmania differentiation process. PLoS ONE 7, e35085 (2012).
ADS CAS PubMed PubMed Central Google Scholar
Chow, C., Cloutier, S., Dumas, C., Chou, M.-N. & Papadopoulou, B. Promastigote to amastigote differentiation of Leishmania is markedly delayed in the absence of PERK eIF2alpha kinase-dependent eIF2alpha phosphorylation. Cell. Microbiol. 13, 1059–1077 (2011).
CAS PubMed Google Scholar
Rochette, A., Raymond, F., Corbeil, J., Ouellette, M. & Papadopoulou, B. Whole-genome comparative RNA expression profiling of axenic and intracellular amastigote forms of Leishmania infantum. Mol. Biochem. Parasitol. 165, 32–47 (2009).
CAS PubMed Google Scholar
Späth, G. F., Drini, S. & Rachidi, N. A touch of Zen: post-translational regulation of the Leishmania stress response. Cell. Microbiol. 17, 632–638 (2015).
PubMed Google Scholar
Haile, S. & Papadopoulou, B. Developmental regulation of gene expression in trypanosomatid parasitic protozoa. Curr. Opin. Microbiol. 10, 569–577 (2007).
CAS PubMed Google Scholar
McConville, M. J. & Naderer, T. Metabolic pathways required for the intracellular survival of Leishmania. Annu. Rev. Microbiol. 65, 543–561 (2011).
CAS PubMed Google Scholar
Naderer, T. & McConville, M. J. Intracellular growth and pathogenesis of Leishmania parasites. Essays Biochem. 51, 81–95 (2011).
CAS PubMed Google Scholar
Pilla, E., Schneider, K. & Bertolotti, A. Coping with protein quality control failure. Annu. Rev. Cell Dev. Biol. 33, 439–465 (2017).
CAS PubMed Google Scholar
Padmanabhan, P. K. et al. DDX3 DEAD-box RNA helicase plays a central role in mitochondrial protein quality control in Leishmania. Cell Death Dis. 7, e2406 (2016).
CAS PubMed PubMed Central Google Scholar
Aguiar, B. G., Padmanabhan, P. K., Dumas, C. & Papadopoulou, B. Valosin-containing protein VCP/p97 is essential for the intracellular development of Leishmania and its survival under heat stress. Cell. Microbiol. 20, e12867 (2018).
Google Scholar
Muñoz, C., San Francisco, J., Gutiérrez, B. & González, J. Role of the ubiquitin-proteasome systems in the biology and virulence of protozoan parasites. Biomed Res. Int. 2015, 1–13 (2015).
Google Scholar
Dolai, S. & Adak, S. Endoplasmic reticulum stress responses in Leishmania. Mol. Biochem. Parasitol. 197, 1–8 (2014).
CAS PubMed Google Scholar
van den Boom, J. & Meyer, H. VCP/p97-mediated unfolding as a principle in protein homeostasis and signaling. Mol. Cell 69, 182–194 (2018).
PubMed Google Scholar
Bodnar, N. O. & Rapoport, T. A. Molecular mechanism of substrate processing by the Cdc48 ATPase complex. Cell 169, 722-735.e9 (2017).
CAS PubMed PubMed Central Google Scholar
Christianson, J. C. & Ye, Y. Cleaning up in the endoplasmic reticulum: ubiquitin in charge. Nat. Struct. Mol. Biol. 21, 325–335 (2014).
CAS PubMed Google Scholar
Ye, Y., Tang, W. K., Zhang, T. & Xia, D. A mighty, “protein extractor” of the cell: structure and function of the p97/CDC48 ATPase. Front. Mol. Biosci. 4, 1–20 (2017).
Google Scholar
Meyer, H., Bug, M. & Bremer, S. Emerging functions of the VCP/p97 AAA-ATPase in the ubiquitin system. Nat. Cell Biol. 14, 117–123 (2012).
CAS PubMed Google Scholar
Franz, A., Ackermann, L. & Hoppe, T. Create and preserve: Proteostasis in development and aging is governed by Cdc48/p97/VCP. Biochim. Biophys. Acta Mol. Cell Res. 1843, 205–215 (2014).
CAS Google Scholar
Qi, L., Tsai, B. & Arvan, P. New insights into the physiological role of endoplasmic reticulum-associated degradation. Trends Cell Biol. 27, 430–440 (2017).
CAS PubMed PubMed Central Google Scholar
Taylor, E. B. & Rutter, J. Mitochondrial quality control by the ubiquitin–proteasome system. Biochem. Soc. Trans. 39, 1509–1513 (2011).
CAS PubMed Google Scholar
Brandman, O. et al. A ribosome-bound quality control complex triggers degradation of nascent peptides and signals translation stress. Cell 151, 1042–1054 (2012).
CAS PubMed PubMed Central Google Scholar
Franz, A., Ackermann, L. & Hoppe, T. Ring of change: CDC48/p97 drives protein dynamics at chromatin. Front. Genet. 7, 1–14 (2016).
Google Scholar
Papadopoulos, C. et al. VCP/p97 cooperates with YOD1, UBXD1 and PLAA to drive clearance of ruptured lysosomes by autophagy. EMBO J. 36, 135–150 (2017).
CAS PubMed Google Scholar
Vaz, B., Halder, S. & Ramadan, K. Role of p97/VCP (Cdc48) in genome stability. Front. Genet. 4, 60 (2013).
PubMed PubMed Central Google Scholar
Buchan, J. R., Kolaitis, R.-M., Taylor, J. P. & Parker, R. Eukaryotic stress granules are cleared by autophagy and Cdc48/VCP function. Cell 153, 1461–1474 (2013).
CAS PubMed PubMed Central Google Scholar
Fessart, D., Marza, E., Taouji, S., Delom, F. & Chevet, E. P97/CDC-48: proteostasis control in tumor cell biology. Cancer Lett. 337, 26–34 (2013).
CAS PubMed Google Scholar
Meyer, H. & Weihl, C. C. The VCP/p97 system at a glance: connecting cellular function to disease pathogenesis. J. Cell Sci. 127, 3877–3883 (2014).
CAS PubMed PubMed Central Google Scholar
Tang, W. K. & Xia, D. Mutations in the human AAA+ Chaperone p97 and related diseases. Front. Mol. Biosci. 3, 1–12 (2016).
MathSciNet Google Scholar
Xia, D., Tang, W. K. & Ye, Y. Structure and function of the AAA+ ATPase p97/Cdc48p. Gene 583, 64–77 (2016).
CAS PubMed PubMed Central Google Scholar
Buchberger, A., Schindelin, H. & Hänzelmann, P. Control of p97 function by cofactor binding. FEBS Lett. 589, 2578–2589 (2015).
CAS PubMed Google Scholar
Hänzelmann, P. & Schindelin, H. Characterization of an additional binding surface on the p97 N-terminal domain involved in bipartite cofactor interactions. Structure 24, 140–147 (2016).
PubMed Google Scholar
Hänzelmann, P. & Schindelin, H. The interplay of cofactor interactions and post-translational modifications in the regulation of the AAA+ ATPase p97. Front. Mol. Biosci. 4, 1–22 (2017).
Google Scholar
Rezvani, K. UBXD proteins: a family of proteins with diverse functions in cancer. Int. J. Mol. Sci. 17, 1724 (2016).
PubMed Central Google Scholar
Bodnar, N. O. et al. Structure of the Cdc48 ATPase with its ubiquitin-binding cofactor Ufd1–Npl4. Nat. Struct. Mol. Biol. 25, 616–622 (2018).
CAS PubMed PubMed Central Google Scholar
Zhao, G. et al. Studies on peptide:N-glycanase-p97 interaction suggest that p97 phosphorylation modulates endoplasmic reticulum-associated degradation. Proc. Natl. Acad. Sci. 104, 8785–8790 (2007).
ADS CAS PubMed PubMed Central Google Scholar
Weith, M. et al. Ubiquitin-independent disassembly by a p97 AAA-ATPase complex drives PP1 Holoenzyme formation. Mol. Cell 72, 766-777.e6 (2018).
CAS PubMed Google Scholar
Roggy, J. L. & Bangs, J. D. Molecular cloning and biochemical characterization of a VCP homolog in African trypanosomes. Mol. Biochem. Parasitol. 98, 1–15 (1999).
CAS PubMed Google Scholar
Cheng, Y.-L. & Chen, R.-H. Assembly and quality control of the protein phosphatase 1 holoenzyme involves the Cdc48-Shp1 chaperone. J. Cell Sci. 128, 1180–1192 (2015).
CAS PubMed Google Scholar
Lee, J.-J. et al. Complex of fas-associated Factor 1 (FAF1) with valosin-containing protein (VCP)-Npl4-Ufd1 and polyubiquitinated proteins promotes endoplasmic reticulum-associated degradation (ERAD). J. Biol. Chem. 288, 6998–7011 (2013).
CAS PubMed PubMed Central Google Scholar
Mullen, T. D. & Obeid, L. M. Ceramide and apoptosis: exploring the enigmatic connections between sphingolipid metabolism and programmed cell death. Anticancer. Agents Med. Chem. 12, 340–363 (2012).
CAS PubMed Google Scholar
Nikolova-Karakashian, M. N. & Rozenova, K. A. Ceramide in stress response. Adv. Exp. Med. Biol. 688, 86–108 (2010).
CAS PubMed PubMed Central Google Scholar
Oláh, J. et al. Tubulin binding and polymerization promoting properties of tubulin polymerization promoting proteins are evolutionarily conserved. Biochemistry 56, 1017–1024 (2017).
PubMed Google Scholar
Zou, W.-Q., Zhou, X., Yuan, J. & Xiao, X. Insoluble cellular prion protein and its association with prion and Alzheimer diseases. Prion 5, 172–178 (2011).
CAS PubMed PubMed Central Google Scholar
Qi, X., Sun, J. & Zheng, H. A GTPase-dependent fine ER is required for localized secretion in polarized growth of root hairs 1. Plant Physiol. 171, 1996–2007 (2016).
CAS PubMed PubMed Central Google Scholar
Maciver, S. K. & Hussey, P. J. The ADF/cofilin family: actin-remodeling proteins. Genome Biol. 3, reviews3007 (2002).
Marshansky, V., Rubinstein, J. L. & Grüber, G. Eukaryotic V-ATPase: Novel structural findings and functional insights. Biochim. Biophys. Acta - Bioenerg. 1837, 857–879 (2014).
CAS Google Scholar
Mani, J. et al. Mitochondrial protein import receptors in Kinetoplastids reveal convergent evolution over large phylogenetic distances. Nat. Commun. 6, 6646 (2015).
ADS CAS PubMed Google Scholar
Wolf, D. H. & Stolz, A. The Cdc48 machine in endoplasmic reticulum associated protein degradation. Biochim. Biophys. Acta - Mol. Cell Res. 1823, 117–124 (2012).
Heo, J.-M. et al. A stress-responsive system for mitochondrial protein degradation. Mol. Cell 40, 465–480 (2010).
CAS PubMed PubMed Central Google Scholar
Dreveny, I. et al. Structural basis of the interaction between the AAA ATPase p97/VCP and its adaptor protein p47. EMBO J. 23, 1030–1039 (2004).
CAS PubMed PubMed Central Google Scholar
Song, E. J., Yim, S.-H., Kim, E., Kim, N.-S. & Lee, K.-J. Human fas-associated factor 1, interacting with ubiquitinated proteins and valosin-containing protein, is involved in the ubiquitin-proteasome pathway. Mol. Cell. Biol. 25, 2511–2524 (2005).
CAS PubMed PubMed Central Google Scholar
Ye, Y., Shibata, Y., Yun, C., Ron, D. & Rapoport, T. A. A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol. Nature 429, 841–847 (2004).
ADS CAS PubMed Google Scholar
Pye, V. E. et al. Structural insights into the p97-Ufd1-Npl4 complex. Proc. Natl. Acad. Sci. 104, 467–472 (2007).
ADS CAS PubMed PubMed Central Google Scholar
Zhao, G., Li, G., Schindelin, H. & Lennarz, W. J. An Armadillo motif in Ufd3 interacts with Cdc48 and is involved in ubiquitin homeostasis and protein degradation. Proc. Natl. Acad. Sci. 106, 16197–16202 (2009).
ADS CAS PubMed PubMed Central Google Scholar
Kim, S. J. et al. Structural basis for ovarian tumor domain-containing protein 1 (OTU1) binding to p97/Valosin-containing protein (VCP). J. Biol. Chem. 289, 12264–12274 (2014).
CAS PubMed PubMed Central Google Scholar
Stenmark, H., Aasland, R. & Driscoll, P. C. The phosphatidylinositol 3-phosphate-binding FYVE finger. FEBS Lett. 513, 77–84 (2002).
CAS PubMed Google Scholar
Yang, Y. et al. Folding-degradation relationship of a membrane protein mediated by the universally conserved ATP-dependent protease FtsH. J. Am. Chem. Soc. 140, 4656–4665 (2018).
CAS PubMed PubMed Central Google Scholar
Stach, L. & Freemont, P. S. The AAA+ ATPase p97, a cellular multitool. Biochem. J. 474, 2953–2976 (2017).
CAS PubMed Google Scholar
Alexandru, G. et al. UBXD7 binds multiple ubiquitin ligases and implicates p97 in HIF1α turnover. Cell 134, 804–816 (2008).
CAS PubMed PubMed Central Google Scholar
Friant, S. Increased ubiquitin-dependent degradation can replace the essential requirement for heat shock protein induction. EMBO J. 22, 3783–3791 (2003).
CAS PubMed PubMed Central Google Scholar
Meade, J. C., Shaw, J., Lemaster, S., Gallagher, G. & Stringer, J. R. Structure and expression of a tandem gene pair in Leishmania donovani that encodes a protein structurally homologous to eucaryotic cation-transporting ATPases. Mol. Cell. Biol. 7, 3937–3946 (1987).
CAS PubMed PubMed Central Google Scholar
Bharucha, J. P., Larson, J. R., Gao, L., Daves, L. K. & Tatchell, K. Ypi1, a positive regulator of nuclear protein phosphatase type 1 activity in Saccharomyces cerevisiae. Mol. Biol. Cell 19, 1032–1045 (2008).
CAS PubMed PubMed Central Google Scholar
Cheng, Y.-L. & Chen, R.-H. The AAA-ATPase Cdc48 and cofactor Shp1 promote chromosome bi-orientation by balancing Aurora B activity. J. Cell Sci. 123, 2025–2034 (2010).
CAS PubMed Google Scholar
Rumpf, S. & Jentsch, S. Functional division of substrate processing cofactors of the ubiquitin-selective Cdc48 chaperone. Mol. Cell 21, 261–269 (2006).
CAS PubMed Google Scholar
Liu, Y. & Ye, Y. Roles of p97-associated deubiquitinases in protein quality control at the endoplasmic reticulum. Curr. Protein Pept. Sci. 13, 436–446 (2012).
CAS PubMed PubMed Central Google Scholar
Wai, T. et al. The membrane scaffold SLP2 anchors a proteolytic hub in mitochondria containing PARL and the i -AAA protease YME1L. EMBO Rep. 17, 1844–1856 (2016).
CAS PubMed PubMed Central Google Scholar
Janska, H., Kwasniak, M. & Szczepanowska, J. Protein quality control in organelles — AAA/FtsH story. Biochim. Biophys. Acta Mol. Cell Res. 1833, 381–387 (2013).
CAS Google Scholar
Farré, J., Mahalingam, S. S., Proietto, M. & Subramani, S. Peroxisome biogenesis, membrane contact sites, and quality control. EMBO Rep. 20, e46864 (2019).
PubMed Google Scholar
Bauer, S. & Morris, M. T. Glycosome biogenesis in trypanosomes and the de novo dilemma. PLoS Negl. Trop. Dis. 11, e0005333 (2017).
PubMed PubMed Central Google Scholar
Cho, D.-H., Kim, Y. S., Jo, D. S., Choe, S.-K. & Jo, E.-K. Pexophagy: molecular mechanisms and implications for health and diseases. Mol. Cells 41, 55–64 (2018).
CAS PubMed PubMed Central Google Scholar
Cull, B. et al. Glycosome turnover in Leishmania major is mediated by autophagy. Autophagy 10, 2143–2157 (2014).
CAS PubMed Google Scholar
Oh, C.-S., Toke, D. A., Mandala, S. & Martin, C. E. ELO2 and ELO3, homologues of the Saccharomyces cerevisiae ELO1 Gene, function in fatty acid elongation and are required for sphingolipid formation. J. Biol. Chem. 272, 17376–17384 (1997).
CAS PubMed Google Scholar
Lee, S. H., Stephens, J. L., Paul, K. S. & Englund, P. T. Fatty acid synthesis by elongases in trypanosomes. Cell 126, 691–699 (2006).
CAS PubMed Google Scholar
Papadopoulou, B., Roy, G. & Ouellette, M. A novel antifolate resistance gene on the amplified H circle of Leishmania. EMBO J. 11, 3601–3608 (1992).
CAS PubMed PubMed Central Google Scholar
Padmanabhan, P. K. et al. Novel features of a PIWI-like protein homolog in the parasitic protozoan leishmania. PLoS ONE 7, e52612 (2012).
ADS CAS PubMed PubMed Central Google Scholar
Dupé, A., Dumas, C. & Papadopoulou, B. Differential subcellular localization of leishmania alba-domain proteins throughout the parasite development. PLoS ONE 10, e0137243 (2015).
PubMed PubMed Central Google Scholar
Shevchenko, A., Wilm, M., Vorm, O. & Mann, M. Mass spectrometric sequencing of proteins from silver-stained polyacrylamide gels. Anal. Chem. 68, 850–858 (1996).
CAS PubMed Google Scholar
Havliš, J., Thomas, H., Šebela, M. & Shevchenko, A. Fast-response proteomics by accelerated in-gel digestion of proteins. Anal. Chem. 75, 1300–1306 (2003).
PubMed Google Scholar
Nesvizhskii, A. I., Keller, A., Kolker, E. & Aebersold, R. A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 75, 4646–4658 (2003).
CAS PubMed Google Scholar
Eswar, N. et al. Comparative protein structure modeling using MODELLER. Curr. Protoc. Protein Sci. 50, 2.9.1-2.9.31 (2007).
Google Scholar
Laskowski, R., Rullmann, J. A., MacArthur, M., Kaptein, R. & Thornton, J. AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J. Biomol. NMR 8, 477–486 (1996).
CAS PubMed Google Scholar
Yan, Y., Zhang, D., Zhou, P., Li, B. & Huang, S.-Y. HDOCK: a web server for protein–protein and protein–DNA/RNA docking based on a hybrid strategy. Nucleic Acids Res. 45, W365–W373 (2017).
CAS PubMed PubMed Central Google Scholar
Zhou, P., Jin, B., Li, H. & Huang, S.-Y. HPEPDOCK: a web server for blind peptide–protein docking based on a hierarchical algorithm. Nucleic Acids Res. 46, W443–W450 (2018).
CAS PubMed PubMed Central Google Scholar
Sievers, F. & Higgins, D. G. Clustal Omega for making accurate alignments of many protein sequences. Protein Sci. 27, 135–145 (2018).
CAS PubMed Google Scholar
Guindon, S. et al. New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst. Biol. 59, 307–321 (2010).
CAS PubMed Google Scholar
Shannon, P. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498–2504 (2003).
CAS PubMed PubMed Central Google Scholar
Perez-Riverol, Y. et al. The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucleic Acids Res. 47, D442–D450 (2019).
CAS PubMed Google Scholar

Download references

Acknowledgements

We are grateful to the Proteomics platform of the CHU de Quebec Research Center-Université Laval. We also thank Dr. James D. Bangs for having kindly provided the anti-Trypanosoma brucei VCP antibody. BGA is a recipient of doctoral fellowships from the CAPES ‘Frontiers without Borders’ program. This work was supported by the Canadian Institutes of Health Research (CIHR) operating grant MOP-12182 awarded to BP.

Author information

Bruno Guedes Aguiar
Present address: Department of Community Medicine, Federal University of Piauí, Teresina, Brazil

Authors and Affiliations

Division of Infectious Disease and Immunity, CHU de Quebec Research Center-Laval University, 2705 Laurier Blvd, Quebec, QC, G1V 4G2, Canada
Bruno Guedes Aguiar, Carole Dumas, Prasad K. Padmanabhan & Barbara Papadopoulou
Department of Microbiology-Infectious Disease and Immunology, Faculty of Medicine, University Laval, Quebec, QC, G1V 4G2, Canada
Bruno Guedes Aguiar, Carole Dumas, Prasad K. Padmanabhan & Barbara Papadopoulou
Institut de Biologie Intégrative Et Des Systèmes (IBIS), Laval University, Quebec, QC, Canada
Halim Maaroufi

Authors

Bruno Guedes Aguiar
View author publications
You can also search for this author in PubMed Google Scholar
Carole Dumas
View author publications
You can also search for this author in PubMed Google Scholar
Halim Maaroufi
View author publications
You can also search for this author in PubMed Google Scholar
Prasad K. Padmanabhan
View author publications
You can also search for this author in PubMed Google Scholar
Barbara Papadopoulou
View author publications
You can also search for this author in PubMed Google Scholar

Contributions

B.G.A. generated all constructs and performed transfections, IP experiments and western blots, sample preparations for mass spectrometry analysis, and processed all data. H.M. did the 3D homology modeling, docking and phylogeny. C.D. and P.K.P. helped with cell cultures, digitonin fractionation, and immunofluorescence studies. Conceptualization and design of the experiments was done by B.G.A. with the help of B.P. B.G.A. and B.P. wrote the manuscript. B.P. supervised the project and provided funding.

Corresponding author

Correspondence to Barbara Papadopoulou.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Supplementary file1

Supplementary file2

Supplementary file3

Supplementary file4

Supplementary file5

Supplementary file6

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Cite this article

Aguiar, B.G., Dumas, C., Maaroufi, H. et al. The AAA + ATPase valosin-containing protein (VCP)/p97/Cdc48 interaction network in Leishmania. Sci Rep 10, 13135 (2020). https://doi.org/10.1038/s41598-020-70010-4

Download citation

Received: 15 November 2019
Accepted: 14 July 2020
Published: 04 August 2020
DOI: https://doi.org/10.1038/s41598-020-70010-4

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.